O Desafio de Incorporar Tecnologias de Alto Custo: Uma Análise dos Inibidores de PCSK9 / The Challenge of Incorporating High-Cost Technologies: An Analysis of PCSK9 Inhibitors
Arq. bras. cardiol
;
117(5): 997-998, nov. 2021.
Article
in English, Portuguese
| LILACS
| ID: biblio-1350006
Análise de Custo-Benefício; Aterosclerose; Atherosclerosis; Avaliação de Tecnologia Biomédica; Cost-Bebefit Analysis; Gastos em Saúde; Health Expenditures; Proprotein Convertase/therapeutic use; Pró-Proteína Convertase 9/uso terapêutico; Sistema Único de Saúde (SUS); Technology Assessment, Biomedical; Unified Health System
Full text:
Available
Index:
LILACS (Americas)
Main subject:
Proprotein Convertase 9
Type of study:
Health economic evaluation
/
Health technology assessment
Limits:
Humans
Language:
English
/
Portuguese
Journal:
Arq. bras. cardiol
Journal subject:
Cardiology
Year:
2021
Type:
Article
Affiliation country:
Brazil
Institution/Affiliation country:
Universidade Federal do Rio Grande do Sul/BR
Similar
MEDLINE
...
LILACS
LIS